We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a ...
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
Jim Cramer, the host of Mad Money, reflected on the uncertainty surrounding the year 2025, focusing on several macroeconomic ...
Daily Caller on MSN3h
Senate Committees Waging War On RFK Jr.’s MAHA Vision Are Knee Deep In Big Pharma, Food Industry CashContentious hearings to consider Robert F. Kennedy Jr. to lead the Department of Health and Human Services this week have ...
Where Summit Therapeutics ( SMMT -7.92%) falls on that spectrum is a big question mark right now. It has been among the hottest healthcare stocks to own over the past 12 months, as its valuation has ...
Pharmaceutical Technology on MSN12h
Leveragen and Moonlight Bio unite for T-cell therapy developmentLeveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for ...
GlobalData on MSN11h
Shionogi’s RSV antiviral reduces viral load in Phase II human challenge trialShionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...
Robert F. Kennedy Jr. defended his prior public statements on a range of health policy issues in a fiery confirmation ...
It’s time for a new era of public health—where vaccines are seen as both a scientific triumph and a shared commitment to well ...
Volunteers in north Wales are among 25,000 people taking part in a global trial to find a vaccine against the symptoms of the ...
Robert F. Kennedy's nomination will put Republican lawmakers' loyalty to the test, as the former Democrat holds a range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback